Journal
ORGANIC LETTERS
Volume 15, Issue 7, Pages 1678-1681Publisher
AMER CHEMICAL SOC
DOI: 10.1021/ol4004614
Keywords
-
Categories
Funding
- OSU College of Pharmacy
- Environmental Health Sciences Center, Oregon State University, National Institute of Environmental Health Sciences, NIH [P30 ES00210]
Ask authors/readers for more resources
A mutasynthetic strategy has been used to generate fluorinated TM-025 and TM-026, two biosynthetically engineered pactamycin analogues produced by Streptomyces pactum ATCC 27456. The fluorinated compounds maintain excellent activity and selectivity toward chloroquine-sensitive and multidrug-resistant strains of malarial parasites as the parent compounds. The results also provide insights into the biosynthesis of 3-aminobenzoic acid in S. pactum.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
